We found that expression of RPL27A was significantly correlated with immune infiltration in many kinds of cancers such as PRAD, thymoma (THCA), COAD, uterine corpus endometrial carcinoma (UCEC), BRCA, KIRC, LUSC, LUAD, HCC, head-neck squamous cell carcinoma (HNSC), and bladder urothelial carcinoma (BLCA) (Fig. 6a). The gene discussed is RPL27A; the disease is bladder transitional cell carcinoma.